Abstract | OBJECTIVES: Human epididymis protein 4 (HE4) is a new biomarker for the detection of ovarian cancer. The objective of this review was to assess by meta-analysis the overall diagnostic accuracy of HE4 assay in differentiating malignant ovarian tumors from benign gynecology diseases. STUDY DESIGN: The MEDLINE, EMBASE, and Cochrane Library databases were searched for studies published up to June 2012 that evaluated HE4 accuracy. Meta-analysis was used to calculate sensitivity, specificity, the positive likelihood ratio (PLR), the negative likelihood ratio (NLR) and the area under curve (AUC). RESULTS: A total of 11 studies with 3395 patients who fulfilled all inclusion criteria were considered in the analysis. No publication bias was found. HE4 had a pooled sensitivity of 0.74 (95% confidence interval (CI), 0.72-0.76) and a pooled specificity of 0.87 (95% CI, 0.85-0.89). Overall, the positive likelihood ratio was 8.04 (95% CI, 4.89-13.21) and the negative likelihood ratio was 0.27 (95% CI, 0.22-0.34). When HE4 was combined with CA125, the sensitivity was higher than that of HE4 alone at the expense of lower specificity. CONCLUSIONS:
|
Authors | JiaYing Lin, JinBao Qin, Voramon Sangvatanakul |
Journal | European journal of obstetrics, gynecology, and reproductive biology
(Eur J Obstet Gynecol Reprod Biol)
Vol. 167
Issue 1
Pg. 81-5
(Mar 2013)
ISSN: 1872-7654 [Electronic] Ireland |
PMID | 23228410
(Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Review, Systematic Review)
|
Copyright | Copyright © 2012 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Biomarkers, Tumor
- Proteins
- WAP Four-Disulfide Core Domain Protein 2
- WFDC2 protein, human
|
Topics |
- Biomarkers, Tumor
(blood)
- Diagnosis, Differential
- Female
- Humans
- Ovarian Neoplasms
(blood, diagnosis)
- Proteins
(metabolism)
- Sensitivity and Specificity
- WAP Four-Disulfide Core Domain Protein 2
|